11-89284797-G-T

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PS1PM2PP3_StrongPP5_Very_Strong

The NM_000372.5(TYR):​c.1209G>T​(p.Arg403Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,611,534 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Pathogenicin Lovd.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000021 ( 0 hom. )

Consequence

TYR
NM_000372.5 missense

Scores

7
7
5

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:7O:1

Conservation

PhyloP100: -0.0450
Variant links:
Genes affected
TYR (HGNC:12442): (tyrosinase) The enzyme encoded by this gene catalyzes the first 2 steps, and at least 1 subsequent step, in the conversion of tyrosine to melanin. The enzyme has both tyrosine hydroxylase and dopa oxidase catalytic activities, and requires copper for function. Mutations in this gene result in oculocutaneous albinism, and nonpathologic polymorphisms result in skin pigmentation variation. The human genome contains a pseudogene similar to the 3' half of this gene. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PS1
Transcript NM_000372.5 (TYR) is affected with MISSENSE_VARIANT having same AA change as one Pathogenic present in Lovd
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.977
PP5
Variant 11-89284797-G-T is Pathogenic according to our data. Variant chr11-89284797-G-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3800.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-89284797-G-T is described in Lovd as [Pathogenic]. Variant chr11-89284797-G-T is described in Lovd as [Likely_pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TYRNM_000372.5 linkuse as main transcriptc.1209G>T p.Arg403Ser missense_variant 4/5 ENST00000263321.6 NP_000363.1 P14679-1L8B082
TYRXM_011542970.3 linkuse as main transcriptc.1209G>T p.Arg403Ser missense_variant 4/6 XP_011541272.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TYRENST00000263321.6 linkuse as main transcriptc.1209G>T p.Arg403Ser missense_variant 4/51 NM_000372.5 ENSP00000263321.4 P14679-1
TYRENST00000528243.1 linkuse as main transcriptn.207G>T non_coding_transcript_exon_variant 2/35

Frequencies

GnomAD3 genomes
AF:
0.00000659
AC:
1
AN:
151736
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000359
AC:
9
AN:
250392
Hom.:
0
AF XY:
0.0000222
AC XY:
3
AN XY:
135336
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000796
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000212
AC:
31
AN:
1459798
Hom.:
0
Cov.:
32
AF XY:
0.0000193
AC XY:
14
AN XY:
726270
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000177
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000207
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000659
AC:
1
AN:
151736
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74088
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000200
Hom.:
0
Bravo
AF:
0.00000378
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000494
AC:
6
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:3Other:1
Likely pathogenic, criteria provided, single submitterclinical testingGeneDxJul 22, 2016The R403S variant in the TYR gene has been reported previously in individuals who underwent genetic testing for oculocutaneous albinism type 1 (Opitz et al., 2004; Oetting et al., 1993; Hutton et al., 2008). The R403S variant was not observed at any significant frequency in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R403S variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is not conserved; however, in silico analysis predicts this variant is probably damaging to the protein structure/function. Additionally, missense variants in nearby residues (E398V, E398G, W400L, W400C, R402G, R402L, H404N, H404P, R405L, P406L, Q408H) have been reported in the Human Gene Mutation Database in association with oculocutaneous albinism type 1 (Stenson et al., 2014), supporting the functional importance of this region of the protein. The R403S variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded. -
not provided, no classification providedliterature onlyRetina International-- -
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpOct 15, 2023This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 403 of the TYR protein (p.Arg403Ser). This variant is present in population databases (rs104894316, gnomAD 0.007%). This missense change has been observed in individuals with oculocutaneous albinism (PMID: 1642278, 10987646, 18463683). ClinVar contains an entry for this variant (Variation ID: 3800). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TYR protein function. For these reasons, this variant has been classified as Pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJan 01, 2022- -
Tyrosinase-negative oculocutaneous albinism Pathogenic:2
Pathogenic, no assertion criteria providedliterature onlyOMIMJul 15, 1992- -
Likely pathogenic, criteria provided, single submitterclinical testingGenome-Nilou LabJul 22, 2021- -
Oculocutaneous albinism Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpSep 20, 2023Variant summary: TYR c.1209G>T (p.Arg403Ser) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.6e-05 in 250392 control chromosomes. c.1209G>T has been reported at a compound heterozygous state along with different apparently pathogenic variants in multiple individuals affected with Oculocutaneous Albinism (examples, Tripathi_1992, Passmore_1999, Hutton_2008) . These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 18463683, 10987646, 1642278). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsFeb 20, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.36
BayesDel_addAF
Pathogenic
0.34
D
BayesDel_noAF
Pathogenic
0.43
CADD
Benign
18
DANN
Uncertain
0.98
DEOGEN2
Pathogenic
0.96
D
Eigen
Benign
-0.35
Eigen_PC
Benign
-0.43
FATHMM_MKL
Benign
0.64
D
LIST_S2
Uncertain
0.96
D
M_CAP
Uncertain
0.20
D
MetaRNN
Pathogenic
0.98
D
MetaSVM
Pathogenic
0.90
D
MutationAssessor
Pathogenic
3.4
M
PrimateAI
Benign
0.34
T
PROVEAN
Uncertain
-3.5
D
REVEL
Pathogenic
0.72
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0080
D
Polyphen
0.34
B
Vest4
0.95
MutPred
0.82
Loss of solvent accessibility (P = 0.1301);
MVP
0.93
MPC
0.012
ClinPred
0.62
D
GERP RS
0.027
Varity_R
0.57
gMVP
0.90

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs104894316; hg19: chr11-89017965; API